- Details
- Description
Strength:
Alectinib Hydrochloride INN 150 mg
Composition:
Alectinib Hydrochloride 150 mg
Treatment:
ALK-positive Non-Small Cell Lung Cancer (NSCLC)
Form:
Capsule
Brand:
Alecnib
Quantity Unit:
Capsules
Manufacturer:
Everest Pharmaceuticals Ltd.
Alecnib (Alectinib Hydrochloride INN 150 mg) is an oral targeted anticancer medicine from Everest Pharmaceuticals Ltd., containing alectinib, an ALK tyrosine kinase inhibitor. It is used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). Alectinib works by blocking abnormal ALK signaling, helping inhibit the growth and spread of cancer cells. Everest lists Alecnib under its Oncology products.
